Exact Mass: 253.14665639999998
Exact Mass Matches: 253.14665639999998
Found 342 metabolites which its exact mass value is equals to given mass value 253.14665639999998,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Irgarol
C11H19N5S (253.13610939999998)
CONFIDENCE standard compound; INTERNAL_ID 55; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8830; ORIGINAL_PRECURSOR_SCAN_NO 8829 CONFIDENCE standard compound; INTERNAL_ID 55; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8893; ORIGINAL_PRECURSOR_SCAN_NO 8891 CONFIDENCE standard compound; INTERNAL_ID 55; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8806; ORIGINAL_PRECURSOR_SCAN_NO 8802 CONFIDENCE standard compound; INTERNAL_ID 55; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8852; ORIGINAL_PRECURSOR_SCAN_NO 8850 CONFIDENCE standard compound; INTERNAL_ID 55; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8811; ORIGINAL_PRECURSOR_SCAN_NO 8810 CONFIDENCE standard compound; INTERNAL_ID 55; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8878; ORIGINAL_PRECURSOR_SCAN_NO 8875 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1011 CONFIDENCE standard compound; EAWAG_UCHEM_ID 302 CONFIDENCE standard compound; INTERNAL_ID 4008 CONFIDENCE standard compound; INTERNAL_ID 8798 CONFIDENCE standard compound; INTERNAL_ID 4034
Proguanil
C11H16ClN5 (253.10941659999997)
Proguanil is a prophylactic antimalarial drug, which works by stopping the malaria parasite, Plasmodium falciparum and Plasmodium vivax, from reproducing once it is in the red blood cells. It does this by inhibiting the enzyme, dihydrofolate reductase, which is involved in the reproduction of the parasite. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BB - Biguanides D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D007004 - Hypoglycemic Agents > D001645 - Biguanides D009676 - Noxae > D000963 - Antimetabolites
Penciclovir
C10H15N5O3 (253.11748400000002)
Penciclovir is only found in individuals that have used or taken this drug. It is a guanine analogue antiviral drug used for the treatment of various herpesvirus infections. It is a nucleoside analogue which exhibits low toxicity and good selectivity. [Wikipedia]Penciclovir has in vitro activity against herpes simplex virus types 1 (HSV-1) and 2 (HSV-2). In cells infected with HSV-1 or HSV-2, viral thymidine kinase phosphorylates penciclovir to a monophosphate form. The monophosphate form of the drug is then converted to penciclovir triphosphate by cellular kinases. The intracellular triphosphate of penciclovir is retained in vitro inside HSV-infected cells for 10-20 hours, compared with 0.7-1 hour for acyclovir. in vitro studies show that penciclovir triphosphate selectively inhibits viral DNA polymerase by competing with deoxyguanosine triphosphate. Inhibition of DNA synthesis of virus-infected cells inhibits viral replication. In cells not infected with HSV, DNA synthesis is unaltered. Resistant mutants of HSV can occur from qualitative changes in viral thymidine kinase or DNA polymerase. The most commonly encountered acyclovir-resistant mutants that are deficient in viral thymidine kinase are also resistant to penciclovir. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BB - Antivirals D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 3288 KEIO_ID P157; [MS2] KO009149 KEIO_ID P157 Penciclovir (VSA 671) is a potent and selective anti-herpesvirus agent with EC50 values of 0.5, 0.8 μg/ml for HSV-1 (HFEM), HSV-2 (MS), respectively. Penciclovir shows anti-herpesvirus activity with no-toxic. Penciclovir preventes mortality in mouse[1][2].
Pyricarbate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites Same as: D01396
Cinnamyl anthranilate
Prohibited from use in food. Prohibited from use in food
2-({[(4-methoxyphenyl)methyl](methyl)amino}methyl)-2-methylpropane-1,3-diol
Triamterene
Triamterene, also known as dyrenium or ademin, belongs to the class of organic compounds known as pteridines and derivatives. These are polycyclic aromatic compounds containing a pteridine moiety, which consists of a pyrimidine fused to a pyrazine ring to form pyrimido(4,5-b)pyrazine. Triamterene is a drug. While there is a lack of randomized controlled trials evaluating the use of triamterene in the treatment of Ménières disease, the typical treatment is 37.5 mg of triamterene with 25 mg of hydrochlorothiazide 1-2 capsules daily. triamterene can be converted into triamterene through the action of the enzyme solute carrier family 22 member 2. In humans, triamterene is involved in the metabolic disorder called the triamterene action pathway. Triamterene directly blocks the epithelial sodium channel (ENaC) on the lumen side of the kidney collecting tubule. Hepatic impairment: Use with caution in people with severe hepatic dysfunction; in cirrhosis, avoid electrolyte and acid/base imbalances that might lead to hepatic encephalopathy. The patents had expired on Dyazide in 1980, but complications arose with the introductions of generics, because the formulation of Dyazide resulted in variable batches that made it impossible for generic manufacturers to show that their versions were bioequivalent. D049990 - Membrane Transport Modulators > D026941 - Sodium Channel Blockers > D062686 - Epithelial Sodium Channel Blockers C - Cardiovascular system > C03 - Diuretics > C03D - Aldosterone antagonists and other potassium-sparing agents C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49186 - Potassium-Sparing Diuretic D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Therapeutic category: 2133 Pteridine
triamterene
D049990 - Membrane Transport Modulators > D026941 - Sodium Channel Blockers > D062686 - Epithelial Sodium Channel Blockers C - Cardiovascular system > C03 - Diuretics > C03D - Aldosterone antagonists and other potassium-sparing agents C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49186 - Potassium-Sparing Diuretic D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Therapeutic category: 2133 CONFIDENCE standard compound; INTERNAL_ID 638; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6193; ORIGINAL_PRECURSOR_SCAN_NO 6191 CONFIDENCE standard compound; INTERNAL_ID 638; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6227; ORIGINAL_PRECURSOR_SCAN_NO 6226 CONFIDENCE standard compound; INTERNAL_ID 638; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6223; ORIGINAL_PRECURSOR_SCAN_NO 6220 CONFIDENCE standard compound; INTERNAL_ID 638; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6239; ORIGINAL_PRECURSOR_SCAN_NO 6237 CONFIDENCE standard compound; INTERNAL_ID 638; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6243; ORIGINAL_PRECURSOR_SCAN_NO 6241 CONFIDENCE standard compound; INTERNAL_ID 638; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6249; ORIGINAL_PRECURSOR_SCAN_NO 6248 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3637 CONFIDENCE standard compound; INTERNAL_ID 1109
Ethyl 3-methyl-9H-carbazole-9-carboxylate
Ethyl 3-methyl-9H-carbazole-9-carboxylate is found in herbs and spices. Ethyl 3-methyl-9H-carbazole-9-carboxylate is an alkaloid from the roots of Murraya koenigii (curryleaf tree). Alkaloid from the roots of Murraya koenigii (curryleaf tree). Ethyl 3-methyl-9H-carbazole-9-carboxylate is found in herbs and spices.
Tolpropamine
D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Tolpropamine is an alkylamine H1-antihistamine.
2-Amino-9-[4-hydroxy-2-(hydroxymethyl)butyl]-3H-purin-6-one
C10H15N5O3 (253.11748400000002)
Diethyl 1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
1R-cis-3,3,5-Trimethylcyclohexyl ester5-oxo-L-proline
N-(2-(1-Naphthalenyl)ethyl)cyclobutanecarboxamide
2-Fluoro-2',3'-dideoxyadenosine
C10H12FN5O2 (253.09749840000003)
2'-Fluoro-2',3'-dideoxyadenosine
C10H12FN5O2 (253.09749840000003)
2-Methyl-3-[4-(pyridin-3-ylmethyl)phenyl]prop-2-enoic acid
Ethacridine
C15H15N3O (253.12150599999998)
D000890 - Anti-Infective Agents C254 - Anti-Infective Agent
Nefopam
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics
Premazepam
C15H15N3O (253.12150599999998)
6-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydroimidazo[1,2-c]pyrimidin-5-one
ethyl 1-cyclohexyl-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylate
nefopam
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics
2-(1-adamantylcarbonyl)hydrazine-1-carbothioamide
C12H19N3OS (253.12487639999998)
(6R,8S)-(+)-herbindole C|(6R,8S)-herbindole C|herbindole C
2.3-di hydroxypropyl-(2-amino-2-deoxy)-beta-D-glucopyranoside
2-methyl-4-(7(9)9H-purin-6-ylamino)-butane-1,2,3-triol|6-(2,3,4-trihydroxy-3-methylbutylamino)purine
C10H15N5O3 (253.11748400000002)
methyl 4-amino-2-(2,3-dihydroxy-3-methylbutyl)benzoate
A benzoate ester that is methyl 4-aminobenzoate substituted by a 2,3-dihydroxy-3-methylbutyl group at position 2. It is isolated from the wood-decayed fungus Xylaria sp.BCC9653 and exhibits potent cytotoxicity against African green monkey kidney fibroblast (Vero) cells.
L-glutamic acid 5-[(4-hydroxyphenyl)-hydrazide]|Xanthodermin|xanthodermine
N-[1-(4-methoxy-6-oxopyran-2-yl)-2-methylbutyl]acetamide
MPL-dm
CONFIDENCE Probable structure via diagnostic evidence, tentative identification (Level 2b); ALGAE_TP_ID 2801
penciclovir
C10H15N5O3 (253.11748400000002)
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BB - Antivirals D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent Penciclovir (VSA 671) is a potent and selective anti-herpesvirus agent with EC50 values of 0.5, 0.8 μg/ml for HSV-1 (HFEM), HSV-2 (MS), respectively. Penciclovir shows anti-herpesvirus activity with no-toxic. Penciclovir preventes mortality in mouse[1][2].
N-[1-(4-methoxy-6-oxopyran-2-yl)-2-methylbutyl]acetamide
N-[1-(4-methoxy-6-oxopyran-2-yl)-2-methylbutyl]acetamide [IIN-based: Match]
N-[1-(4-methoxy-6-oxopyran-2-yl)-2-methylbutyl]acetamide [IIN-based on: CCMSLIB00000848409]
8-Azaspiro[4.5]decane-8-butanoic acid, 7,9-dioxo(buspirone metabolite)
N-[1-(4-Methoxy-2-oxo-2H-pyran-6-yl)-2-methylbutyl]acetamide
2-Methyl-2-propanyl (4-amino-3-nitrophenyl)carbamate
N-[[2-chloro-5-(3-methoxypropyl)phenyl]methyl]cyclopropanamine
5-tert-butyl-2-(diethylaminomethyl)furan-3-carboxylic acid
N-(TERT-BUTOXYCARBONYL)PHOSPHORAMIDIC ACID DIETHYL ESTER
N-[1-(3-chloropyridin-2-yl)piperidin-4-yl]acetamide
C12H16ClN3O (253.09818359999997)
2-tri(propan-2-yl)silyl-1,3-oxazole-5-carbaldehyde
3-(3-METHYL-1,2,4-OXADIAZOL-5-YL)-1-PYRROLIDINECARBOXYLIC ACID1,1-DIMETHYLETHYL ESTER
tert-butyl 2-formyl-7-azaspiro[3.5]nonane-7-carboxylate
Premazepam
C15H15N3O (253.12150599999998)
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
1-ETHYL-2-PYRIDIN-3-YL-1,2,3,4-TETRAHYDRO-NAPHTHALEN-1-OL
2-Propen-1-one,1-(4-aminophenyl)-3-(4-methoxyphenyl)-
2-(5-AMINO-ISOXAZOL-3-YL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
3,3-Dimethyl-3H-spiro[benzo[c]furan-1,4-piperidine] hydrochloride
tert-butyl 3-(2-methyl-2H-tetrazol-5-yl)pyrrolidine-1-carboxylate
6-ethoxy-2,2,4-trimethyl-1H-quinoline,hydrochloride
5-fluoro-2-methoxypyridine-3-boronic acid pinacol ester
N-(3,4-dimethoxyphenyl)-Carbamic acid 1,1-dimethylethyl ester
1H-Spiro[piperidine-4,4-quinazolin]-2(3H)-one hydrochloride ( 1:1)
C12H16ClN3O (253.09818359999997)
ETHYL 4-HYDROXY-2-MORPHOLINOPYRIMIDINE-5-CARBOXYLATE
5-methoxy-2-(pyridin-4-ylmethyl)-2,3-dihydroinden-1-one
3-((TERT-BUTYLDIMETHYLSILYLOXY)METHYL)-5-METHOXYPYRIDINE
5,6-dihydrobenzo[f]isoquinolin-1-yl(trimethyl)silane
C16H19NSi (253.12866939999998)
2-(1-PHENYL-3,4-DIHYDRO-1H-ISOQUINOLIN-2-YL)-ETHANOL
(5-([TERT-BUTYL(DIMETHYL)SILYL]OXY)PYRIDIN-3-YL)BORONIC ACID
C11H20BNO3Si (253.13054400000004)
4,5,7,8-TETRAHYDRO-6H-THIENO[2,3-D]AZEPINE-6-CARBOXYLIC ACID, T-BUTYLESTER
ethyl 2-amino-4,5,6,7,8,9-hexahydrocycloocta[b]thiophene-3-carboxylate
5-chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
C12H17BClNO2 (253.10408020000003)
1-(2-fluoro-4-nitrophenyl)-3,5-dimethylpiperazine
C12H16FN3O2 (253.12264879999998)
3-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
C12H17BClNO2 (253.10408020000003)
[2-(4-fluoro-phenyl)-2-oxo-ethyl]-carbamic acid tert-butyl ester
C13H16FNO3 (253.11141579999997)
ST 91
ST91 is a α2-adrenoceptor (α2AR) agonist. ST91 activates both α2AAR and non-α2AAR subtypes to produce spinal antinociception[1][2][3].
(S)-4-METHYL-3-(4-TRIFLUOROMETHYLPHENYL)OXAZOLIDIN-2-ONE
Ethyl 5-(acetoxymethyl)-4-ethyl-3-methyl-1H-pyrrole-2-carboxylate
4-Amino-3-chlorophenylboronic Acid Pinacol Ester
C12H17BClNO2 (253.10408020000003)
4-(4-ACETYL-PIPERAZIN-1-YL)-2-CHLOROANILINE
C12H16ClN3O (253.09818359999997)
ethyl 3-(ethoxycarbonyl)-1,4-dimethyl-1H-pyrrole-2-acetate
4-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
C12H17BClNO2 (253.10408020000003)
Crilvastatin
D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D004791 - Enzyme Inhibitors > D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors D009676 - Noxae > D000963 - Antimetabolites
ETHYL (1R,5R,6R)-5-(1-ETHYLPROPOXY)-7-AZABICYCLO[4.1.0]HEPT-3-ENE-3-CARBOXYLATE
3-(4-ACETYL-PIPERAZIN-1-YL)-4-CHLOROANILINE
C12H16ClN3O (253.09818359999997)
1-(4-METHOXYBENZYL)-1H-INDAZOL-5-AMINE
C15H15N3O (253.12150599999998)
2-(acetoxymethyl)4-(3-methoxypropoxy)-3-methylpyridine
Benzamide, N-(3,4-dihydro-2H-1-benzopyran-3-yl)-, (+)- (9CI)
Choline bitartrate
It is used as a food additive Choline bitartrate is a vitamin-like essential nutrient, can affect diseases such as liver disease, atherosclerosis and neurological disorders[1][2]. Choline bitartrate is a precursor for the neurotransmitter acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism[3]. Choline bitartrate is a vitamin-like essential nutrient, can affect diseases such as liver disease, atherosclerosis and neurological disorders[1][2]. Choline bitartrate is a precursor for the neurotransmitter acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism[3]. Choline bitartrate is a vitamin-like essential nutrient, can affect diseases such as liver disease, atherosclerosis and neurological disorders[1][2]. Choline bitartrate is a precursor for the neurotransmitter acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism[3].
2-(4-(4-FLUOROPHENYL)-1H-PYRAZOL-3-YL)-6-METHYLPYRIDINE
2-Chloro-3-methylpyridine-4-boronic acid pinacol ester
C12H17BClNO2 (253.10408020000003)
tert-butyl 4-oxo-8-azaspiro[4.5]decane-8-carboxylate
(R)-1-(TERT-BUTOXYCARBONYL)-2-(PROP-2-YN-1-YL)PYRROLIDINE-2-CARBOXYLIC ACID
2-methyl-1-[(4-methylphenyl)methyl]-5,6,7,8-tetrahydro-1H-isoquinoline
Acetic acid,2-thiocyanato-, (1R,2R,4R)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl ester, rel-
4-FLUORO-1,4-PIPERIDINEDICHARBOXYLIC ACID,1(1,1-DIMETHYLETHYL)ESTER, LITHIUM SALT
C11H17FLiNO4 (253.13016040000002)
5-ethyl-5-(4-methyl-1-piperidyl)-1,3-diazinane-2,4,6-trione
2-chloro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
C12H17BClNO2 (253.10408020000003)
2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
C12H17BClNO2 (253.10408020000003)
2-chloro-3-methylpyridine-5-boronic acid pinacol ester
C12H17BClNO2 (253.10408020000003)
4-(TERT-BUTYL)-N,N-DIMETHYL-[1,1-BIPHENYL]-4-AMINE
2-[(1,1-dimethylethoxy)carbonyl]hydrazide, 1-oxide
tert-butyl 2-(5-cyclopropyl-1H-tetrazol-1-yl)ethylcarbamate
1,2,3,4-tetrahydro-N-(4-methoxyphenyl)-1-Naphthalenamine
2-Chloro-5-Methylpyridine-3-boronic acid pinacol ester
C12H17BClNO2 (253.10408020000003)
2-(3-oxodecahydroquinoxalin-2-yl)-N-propylacetamide
1-Benzooxazol-2-yl-piperidin-4-ylaMine hydrochloride
C12H16ClN3O (253.09818359999997)
3-fluoro-4-(2-(pyrrolidin-1-yl)ethoxy)phenylboronic acid
(2-fluoro-4-((4-hydroxypiperidin-1-yl)Methyl)phenyl)boronic acid
3,3-Dimethyl-3H-spiro[isobenzofuran-1,4-piperidine] hydrochloride
3-(2-Ethoxycarbonyl-ethyl)-5-methyl-1H-pyrrole-2-carboxylic acid ethyl ester
benzyl (3S,4R)-4-fluoro-3-hydroxypiperidine-1-carboxylate
C13H16FNO3 (253.11141579999997)
4,6-Dihydro-pyrrolo[3,4-c]pyrazole-3,5(1H)-dicarboxylic acid 5-(1,1-dimethylethyl) ester
(2S)-2-amino-6-[(2-methylpropan-2-yl)oxy]-6-oxohexanoic acid
trans-1-cbz-3-fluoro-4-hydroxypiperidine
C13H16FNO3 (253.11141579999997)
tert-butyl 8-oxo-2-azaspiro[4.5]decane-2-carboxylate
4-(1-ISOPROPYL-1H-PYRROLO[2,3-C]PYRIDIN-3-YL)PYRIMIDIN-2-AMINE
2-TERT-BUTYL 4-METHYL 3,5-DIMETHYL-1H-PYRROLE-2,4-DICARBOXYLATE
2-(4-ACETYL-PIPERAZIN-1-YL)-5-CHLOROANILINE
C12H16ClN3O (253.09818359999997)
TERT-BUTYL 3-[5-(2-AMINO-ETHYL)-THIOPHEN-3-YL]-ACRYLATE
2-(4-ACETYL-PIPERAZIN-1-YL)-6-CHLOROANILINE
C12H16ClN3O (253.09818359999997)
2-(4-ACETYL-PIPERAZIN-1-YL)-3-CHLOROANILINE
C12H16ClN3O (253.09818359999997)
acrylic acid, butyl prop-2-enoate, prop-2-enenitrile
Trimethyldiphenylpropylamine
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders
Tesimide
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
2-Methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid
D004791 - Enzyme Inhibitors
9-(4-Hydroxy-2-(hydroxymethyl)butyl)guanine
C10H15N5O3 (253.11748400000002)
N-(2,4-dimethylphenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
N-(2,3-Dihydro-1H-inden-5-yl)-5-methyl-2-pyrazinecarboxamide
C15H15N3O (253.12150599999998)
n-[2-(3,4-Dimethoxyphenyl)ethyl]-1,1,1-trimethylsilanamine
1-[4-(2-Oxo-2-Phenylethyl)phenyl]guanidine
C15H15N3O (253.12150599999998)
2-(2-Hydroxy-phenyl)-1h-benzoimidazole-5-carboxamidine
Pyricarbate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites Same as: D01396
Ethacridine
C15H15N3O (253.12150599999998)
D000890 - Anti-Infective Agents C254 - Anti-Infective Agent
tolpropamine
D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
1-(1-Adamantylcarbonyl)thiosemicarbazide
C12H19N3OS (253.12487639999998)
(1S)-1-[(2S)-2-amino-4-methylpentanamido]ethyl(methoxy)phosphinate
C9H22N2O4P+ (253.13171219999998)
4-Methylene-2-octyl-5-oxotetrahydrofuran-3-carboxyllate
6-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydroimidazo[1,2-c]pyrimidin-5-one
2-Amino-4-(5-methylfuran-2-yl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile
C15H15N3O (253.12150599999998)
2-{2-[4-(Dimethylamino)phenyl]ethenyl}-1-ethylpyridin-1-ium
N-(2-ethoxyphenyl)-1H-benzimidazol-2-amine
C15H15N3O (253.12150599999998)
N-tert-butyl-1,2-dihydroacenaphthylene-5-carboxamide
2-fluoro-N-[(2-methyl-3-indolylidene)amino]aniline
1-(3-Methyl-5-nitroimidazol-4-yl)piperidine-4-carboxamide
C10H15N5O3 (253.11748400000002)
Silanamine, 1,1,1-trimethyl-N-[3-[(trimethylsilyl)oxy]phenyl]-
C12H23NOSi2 (253.13181079999998)
Proguanil
C11H16ClN5 (253.10941659999997)
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BB - Biguanides D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D007004 - Hypoglycemic Agents > D001645 - Biguanides D009676 - Noxae > D000963 - Antimetabolites
cyclo(Pro-Arg)
A homodetic cyclic peptide resulting from the formal condensation of both the amino and acid groups of proline with the acid and amino groups of arginine. It is found in the deep-sea sponge Geodia barretti.
Adenine (hemisulfate)
Adenine hemisulfate (6-Aminopurine hemisulfate), a purine, is one of the four nucleobases in the nucleic acid of DNA. Adenine hemisulfate acts as a chemical component of DNA and RNA. Adenine hemisulfate also plays an important role in biochemistry involved in cellular respiration, the form of both ATP and the cofactors (NAD and FAD), and protein synthesis[1][2]. Adenine hemisulfate (6-Aminopurine hemisulfate), a purine, is one of the four nucleobases in the nucleic acid of DNA. Adenine hemisulfate acts as a chemical component of DNA and RNA. Adenine hemisulfate also plays an important role in biochemistry involved in cellular respiration, the form of both ATP and the cofactors (NAD and FAD), and protein synthesis[1][2].
Omaciclovir
C10H15N5O3 (253.11748400000002)
Omaciclovir (H2G) is a potent and selective inhibitor of herpesvirus replication. Omaciclovir is a nucleoside analog with antiviral activity[1].
n-[(1e)-2-(4-methoxyphenyl)ethenyl]benzenecarboximidic acid
4-[(1e)-but-1-en-1-yl]-5,6,8-trimethyl-1h,6h,7h,8h-cyclopenta[g]indole
(2s)-2-amino-n-[hydroxy(methoxy)phosphoryl]-n,4-dimethylpentanehydrazonic acid
(2r)-2-[(4r)-2-iminoimidazolidin-4-yl]-3-[(2r)-4-methyl-5-oxo-2h-furan-2-yl]propanoic acid
(3z,4s)-4-(1-methylimidazol-4-yl)-3-(phenylmethylidene)-4,5-dihydropyrrol-2-ol
C15H15N3O (253.12150599999998)
(2r,3s,4r,5r,6r)-5-amino-6-[(2r)-2,3-dihydroxypropoxy]-2-(hydroxymethyl)oxane-3,4-diol
n-{3-[(3s,8as)-1-hydroxy-4-oxo-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-3-yl]propyl}guanidine
(5s)-5-(4-methoxyphenyl)-2-phenyl-4,5-dihydro-1,3-oxazole
n-(3-{1-hydroxy-4-oxo-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-3-yl}propyl)guanidine
3-phenyl-6,7,8,9-tetrahydro-5λ⁵-quinolizin-5-ylium-4-carboxylate
(2r,3r)-2-methyl-4-(3h-purin-6-ylamino)butane-1,2,3-triol
C10H15N5O3 (253.11748400000002)
4-(1,5-dihydroxyhex-2-en-1-ylidene)-5-hydroxy-2-isopropyl-2h-pyrrol-3-one
(2e)-n-[(2r)-2-ethyl-5-methyl-3-oxofuran-2-yl]-5-hydroxy-3-methylpent-2-enimidic acid
(1s,2s,8r,11r,14r)-14-hydroxy-12,12-dimethyl-9,13-dioxa-6-azatetracyclo[6.6.0.0¹,¹¹.0²,⁶]tetradecan-10-one
2-methyl-4-(3h-purin-6-ylamino)butane-1,2,3-triol
C10H15N5O3 (253.11748400000002)
n-{3-[(3s,8ar)-1-hydroxy-4-oxo-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-3-yl]propyl}guanidine
(2s)-2-amino-4-[(3-hydroxyphenyl)-c-hydroxycarbonohydrazonoyl]butanoic acid
14-hydroxy-12,12-dimethyl-9,13-dioxa-6-azatetracyclo[6.6.0.0¹,¹¹.0²,⁶]tetradecan-10-one
(2s,3s,4s,9'as)-3-hydroxy-4-methyl-hexahydro-1'h-spiro[oxolane-2,9'-pyrrolo[1,2-a]azepine]-3',5-dione
5-amino-6-(2,3-dihydroxypropoxy)-2-(hydroxymethyl)oxane-3,4-diol
n-[1-(4-methoxy-6-oxopyran-2-yl)-3-methylbutyl]ethanimidic acid
1-(hydroxymethyl)-6,7-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-5-ol
(4s)-4,5-dihydroxy-4-[(2e)-5-hydroxyhex-2-en-1-yl]-2-(propan-2-ylidene)pyrrol-3-one
n-[(1s)-1-(4-methoxy-6-oxopyran-2-yl)-3-methylbutyl]ethanimidic acid
n-[(1s,2s)-1-(4-methoxy-6-oxopyran-2-yl)-2-methylbutyl]ethanimidic acid
(2s)-2-amino-4-[(2-hydroxyphenyl)-c-hydroxycarbonohydrazonoyl]butanoic acid
(4e)-5-hydroxy-4-(1-hydroxydecylidene)-2h-pyrrol-3-one
2-amino-4-[(4-hydroxyphenyl)-c-hydroxycarbonohydrazonoyl]butanoic acid
(2e)-n-[(2s)-2-ethyl-5-methyl-3-oxofuran-2-yl]-5-hydroxy-3-methylpent-2-enimidic acid
2-amino-4-[(2-hydroxyphenyl)-c-hydroxycarbonohydrazonoyl]butanoic acid
(2s)-2-amino-4-[(4-hydroxyphenyl)-c-hydroxycarbonohydrazonoyl]butanoic acid
n-[1-(4-methoxy-6-oxopyran-2-yl)-2-methylbutyl]ethanimidic acid
5,6,7,8-tetramethoxy-1,2,3,4-tetrahydroisoquinoline
(2s,4e)-4-[(2e)-1,5-dihydroxyhex-2-en-1-ylidene]-5-hydroxy-2-isopropyl-2h-pyrrol-3-one
6-[(1r,2s)-1,2-dihydroxypropyl]-2-imino-3-methyl-4a,8a-dihydro-1h-pteridin-4-one
C10H15N5O3 (253.11748400000002)